Abstract
Proteases are critical proteins involved in cleaving substrates that may impact biological pathways, cellular processes, or disease progression. In the biopharmaceutical industry, modulating the levels of protease activity is an important strategy for mitigating many types of diseases. While a variety of analytical tools exist for characterizing substrate cleavages, in vitro functional screening for antibody inhibitors of protease activity using physiologically relevant intact protein substrates remains challenging. In addition, detecting such large protein substrates with high heterogeneity using high-throughput mass spectrometry screening has rarely been reported in the literature with concerns for assay robustness and sensitivity. In this study, we established a peptide-based in vitro functional screening assay for antibody inhibitors of mouse bone morphogenic protein 1 (mBMP1) metalloprotease using a heterogeneous recombinant 66-kDa mouse Procollagen I alpha 1 chain (mProcollagen) substrate. We compared several analytical tools including capillary gel electrophoresis Western blot (CE-Western blot), as well as both intact protein and peptide-based mass spectrometry (MS) to quantitate the mBMP1 proteolytic activity and its inhibition by antibodies using this heterogeneous mProcollagen substrate. We concluded that the peptide-based mass spectrometry screening assay was the most suitable approach in terms of throughput, sensitivity, and assay robustness. We then optimized our mBMP1 proteolysis reaction after characterizing the enzyme kinetics using the peptide-based MS assay. This assay resulted in Z′ values ranging from 0.6 to 0.8 from the screening campaign. Among over 1200 antibodies screened, IC50 characterization was performed on the top candidate hits, which showed partial or complete inhibitory activities against mBMP1.
Graphical abstract
Similar content being viewed by others
References
Turtle ED, Ho W-B. Inhibition of procollagen C-proteinase: fibrosis and beyond. Expert Opin Ther Pat. 2005;14(8):1185–97.
N’Diaye EN, Cook R, Wang H, Wu P, LaCanna R, Wu C, et al. Extracellular BMP1 is the major proteinase for COOH-terminal proteolysis of type I procollagen in lung fibroblasts. Am J Physiol Cell Physiol. 2021;320(2):C162–74.
Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, et al. Potent and selective nonpeptidic inhibitors of procollagen C-proteinase. J Med Chem. 2007;50(15):3442–56.
Dankwardt SM, Abbot SC, Broka CA, Martin RL, Chan CS, Springman EB, et al. Amino acid derived sulfonamide hydroxamates as inhibitors of procollagen C-proteinase. Part 2: Solid-phase optimization of side chains. Bioorg Med Chem Lett. 2002;12(8):1233–5.
Kallander LS, Washburn D, Hilfiker MA, Eidam HS, Lawhorn BG, Prendergast J, et al. Reverse hydroxamate inhibitors of bone morphogenetic protein 1. ACS Med Chem Lett. 2018;9(7):736–40.
Turtle E, Chow N, Yang C, Sosa S, Bauer U, Brenner M, et al. Design and synthesis of procollagen C-proteinase inhibitors. Bioorg Med Chem Lett. 2012;22(24):7397–401.
Vandenbroucke RE, Libert C. Is there new hope for therapeutic matrix metalloproteinase inhibition? Nat Rev Drug Discov. 2014;13(12):904–27.
Heard ME, Besio R, Weis M, Rai J, Hudson DM, Dimori M, et al. Sc65-null mice provide evidence for a novel endoplasmic reticulum complex regulating collagen Lysyl hydroxylation. PLoS Genet. 2016;12(4): e1006002.
Bernhard OK, Kapp EA, Simpson RJ. Enhanced analysis of the mouse plasma proteome using cysteine-containing tryptic glycopeptides. J Proteome Res. 2007;6(3):987–95.
Lundby A, Secher A, Lage K, Nordsborg NB, Dmytriyev A, Lundby C, et al. Quantitative maps of protein phosphorylation sites across 14 different rat organs and tissues. Nat Commun. 2012;3:876.
Li W, Srikumar N, Forrest WF, Ellerman D, Gu C, Tchelepi R, et al. Characterizing and quantitating therapeutic tethered multimeric antibody degradation using affinity capture mass spectrometry. Anal Chem. 2020;92(10):6839–43.
Lange V, Picotti P, Domon B, Aebersold R. Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol. 2008;4:222.
Xu D, Marchionni K, Hu Y, Zhang W, Sosic Z. Quantitative analysis of a biopharmaceutical protein in cell culture samples using automated capillary electrophoresis (CE) western blot. J Pharm Biomed Anal. 2017;145:10–5.
Chen JQ, Wakefield LM, Goldstein DJ. Capillary nano-immunoassays: advancing quantitative proteomics analysis, biomarker assessment, and molecular diagnostics. J Transl Med. 2015;13:182.
Michels DA, Tu AW, McElroy W, Voehringer D, Salas-Solano O. Charge heterogeneity of monoclonal antibodies by multiplexed imaged capillary isoelectric focusing immunoassay with chemiluminescence detection. Anal Chem. 2012;84(12):5380–6.
Donnelly DP, Rawlins CM, DeHart CJ, Fornelli L, Schachner LF, Lin Z, et al. Best practices and benchmarks for intact protein analysis for top-down mass spectrometry. Nat Methods. 2019;16(7):587–94.
Picotti P, Aebersold R. Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat Methods. 2012;9(6):555–66.
Addona TA, Abbatiello SE, Schilling B, Skates SJ, Mani DR, Bunk DM, et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol. 2009;27(7):633–41.
Vanderporten E, Frick L, Turincio R, Thana P, Lamarr W, Liu Y. Label-free high-throughput assays to screen and characterize novel lactate dehydrogenase inhibitors. Anal Biochem. 2013;441(2):115–22.
Li KS, Quinn JG, Saabye MJ, Guerrero JFS, Nonomiya J, Lian Q, et al. High-throughput kinetic characterization of irreversible covalent inhibitors of KRAS(G12C) by intact protein MS and targeted MRM. Anal Chem. 2022;94(2):1230–9.
McLaren DG, Shah V, Wisniewski T, Ghislain L, Liu C, Zhang H, et al. High-throughput mass spectrometry for hit identification: current landscape and future perspectives. SLAS discovery : advancing life sciences R & D. 2021;26(2):168–91.
Ng D, Zhou M, Zhan D, Yip S, Ko P, Yim M, et al. Development of a targeted integration Chinese hamster ovary host directly targeting either one or two vectors simultaneously to a single locus using the Cre/Lox recombinase-mediated cassette exchange system. Biotechnol Prog. 2021;37(4): e3140.
Hojima Y, van der Rest M, Prockop DJ. Type I procollagen carboxyl-terminal proteinase from chick embryo tendons. Purification and characterization. J Biol Chem. 1985;260(29):15996–6003.
Moschcovich L, Kessler E. Data comparing the kinetics of procollagen type I processing by bone morphogenetic protein 1 (BMP-1) with and without procollagen C-proteinase enhancer 1 (PCPE-1). Data Brief. 2016;9:883–7.
Zhang JH, Chung TD, Oldenburg KR. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen. 1999;4(2):67–73.
Chassaing C, Stafford H, Luckwell J, Wright A, Edgington A. A parallel micro turbulent flow chromatography-tandem mass spectrometry method for the analysis of a pharmaceutical compound in plasma. Chromatographia. 2005;62(1):17–24.
Sawyer WS, Srikumar N, Carver J, Chu PY, Shen A, Xu A, et al. High-throughput antibody screening from complex matrices using intact protein electrospray mass spectrometry. Proc Natl Acad Sci U S A. 2020;117(18):9851–6.
Acknowledgements
We thank Shirley Ng, Andy Chang, and Maureen Beresini for their assistance with automation; Eric Torres and Dan Hascall for their informatic support; and Suk Hyung, Sherry Ke Li, Yiming Xu, and Jonathan Josephs for reviewing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wu, C., Cook, R., Wu, P. et al. Using a peptide-based mass spectrometry approach to quantitate proteolysis of an intact heterogeneous procollagen substrate by BMP1 for antagonistic antibody screening. Anal Bioanal Chem 414, 6601–6610 (2022). https://doi.org/10.1007/s00216-022-04220-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-022-04220-2